153 related articles for article (PubMed ID: 9240498)
1. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation.
Ohta S; Yokoyama H; Ise T; Takasawa K; Wada T; Nakao S; Matsuda T; Kobayashi K
Intern Med; 1997 Jul; 36(7):487-91. PubMed ID: 9240498
[TBL] [Abstract][Full Text] [Related]
2. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis.
Or R; Naparstek E; Mani N; Slavin S
Transpl Int; 1991 Jun; 4(2):99-102. PubMed ID: 1910437
[TBL] [Abstract][Full Text] [Related]
4. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
Benjamin RJ; Connors JM; McGurk S; Churchill WH; Antin JH
Biol Blood Marrow Transplant; 1998; 4(3):151-6. PubMed ID: 9923413
[TBL] [Abstract][Full Text] [Related]
5. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
7. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
[No Abstract] [Full Text] [Related]
8. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
9. Delayed erythropoiesis after major ABO-incompatible bone marrow transplantation: report of a case.
Tang JL; Lin MT; Wang CH; Lin DT; Chen YC
J Formos Med Assoc; 1990 Oct; 89(10):892-5. PubMed ID: 1981778
[TBL] [Abstract][Full Text] [Related]
10. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
[TBL] [Abstract][Full Text] [Related]
11. Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation.
Au WY; Lie AK; Ma ES; Lau GK; Chan EC; Kwong YL
Transfusion; 2004 Jun; 44(6):946-7. PubMed ID: 15157268
[No Abstract] [Full Text] [Related]
12. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
[TBL] [Abstract][Full Text] [Related]
13. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
14. Long duration of erythrocyte hypoplasia after bone marrow transplantation.
Suzuki N; Kudoh T; Katoh S; Yohtoh Y; Miura J; Kamimura S; Sakuma Y; Fujita S; Chiba S
Acta Paediatr Jpn; 1992 Aug; 34(4):473-5. PubMed ID: 1414339
[TBL] [Abstract][Full Text] [Related]
15. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
16. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin.
Bierman PJ; Warkentin P; Hutchins MR; Klassen LW
Leuk Lymphoma; 1993 Jan; 9(1-2):169-71. PubMed ID: 8477196
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
18. Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation.
Volin L; Ruutu T
Acta Haematol; 1990; 84(4):195-7. PubMed ID: 2125785
[TBL] [Abstract][Full Text] [Related]
19. Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation.
Sahovic EA; Flick J; Graham CD; Stuart RK
Am J Med Sci; 1991 Dec; 302(6):369-73. PubMed ID: 1772122
[TBL] [Abstract][Full Text] [Related]
20. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
